Literature DB >> 15964132

Do prostatic infarction, prostatic inflammation and prostate morphology play a role in acute urinary retention?

Altug Tuncel1, Burcin Uzun, Tugrul Eruyar, Erdem Karabulut, Selda Seckin, Ali Atan.   

Abstract

OBJECTIVE: To investigate whether there is a role of prostatic infarction, prostatic inflammation and prostate morphology in acute urinary retention (AUR) etiology.
METHODS: Ninety-eight consecutive male patients who were admitted to our clinic with either AUR or lower urinary tract symptoms (LUTS) were involved in the study. Patient age ranged from 43 to 88 years (median age 70). Group 1 consisted of 53 (54%) patients with AUR, and Group 2 consisted of 45 (46%) patients with LUTS. In Group 1 and Group 2, 58.4% (n:31) and 62.2% (n:28) of the patients underwent transurethral prostate resection, 41.6% (n:22) and 37.8% (n:17) of the patients underwent suprapubic transvesical prostatectomy, respectively. Each patient was asked about the factors: smoking habits, taking previous general anesthesia and preexisting cardiovascular disease such as hypertention and atherosclerotic coronary vascular disease which may lead to AUR via prostatic infarct. Prostatic infarction, prostatic inflammation and prostatic morphology were examined in the patients' specimen.
RESULTS: Mean age, median serum prostate-specific antigen (PSA) level, and prostatic inflammation ratio were significantly higher in Group 1. There were not significant differences between the groups regarding prostate volume, prostatic infarction ratio and a type of prostatic morphology. In the present study, except for taking previous general anesthesia and preexisting cardiovascular disease, only prostatic inflammation was found important contributory factor on AUR. AUR risk was 3.03 times higher in the patients with prostatic inflammation (95%CI 1.28-7.15) (p = 0.01).
CONCLUSIONS: No significant effect of prostatic infarction was found on occurrence of AUR which was more frequent in elderly patients. Prostatic inflammation may have an important risk factor in AUR etiology. Additionally, serum PSA levels were higher in AUR group. No association was found between a type of prostatic morphology and AUR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964132     DOI: 10.1016/j.eururo.2005.05.001

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  12 in total

1.  Heme oxygenase levels and metaflammation in benign prostatic hyperplasia patients.

Authors:  Giorgio Ivan Russo; Luca Vanella; Tommaso Castelli; Sebastiano Cimino; Giulio Reale; Daniele Urzì; Giovanni Li Volti; Mauro Gacci; Marco Carini; Fabio Motta; Rosario Caltabiano; Lidia Puzzo; Valeria Sorrenti; Giuseppe Morgia
Journal:  World J Urol       Date:  2015-11-30       Impact factor: 4.226

2.  Impact of asymptomatic prostatitis on re-operations due to urethral stricture or bladder neck contracture developed after TUR-P.

Authors:  Omer Gokhan Doluoglu; Cevdet Serkan Gokkaya; Binhan Kagan Aktas; Cetin Volkan Oztekin; Suleyman Bulut; Ali Memis; Mesut Cetinkaya
Journal:  Int Urol Nephrol       Date:  2012-01-18       Impact factor: 2.370

3.  The effect of intraprostatic chronic inflammation on benign prostatic hyperplasia treatment.

Authors:  Young Kee Kwon; Mi Sun Choe; Kyung Won Seo; Chol Hee Park; Hyuk Soo Chang; Byung Hoon Kim; Chun Il Kim
Journal:  Korean J Urol       Date:  2010-04-20

4.  Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort.

Authors:  Jennifer L St Sauver; Aruna V Sarma; Debra J Jacobson; Michaela E McGree; Michael M Lieber; Cynthia J Girman; Ajay Nehra; Steven J Jacobsen
Journal:  Am J Epidemiol       Date:  2009-04-24       Impact factor: 4.897

Review 5.  Inflammatory mediators in the development and progression of benign prostatic hyperplasia.

Authors:  Cosimo De Nunzio; Fabrizio Presicce; Andrea Tubaro
Journal:  Nat Rev Urol       Date:  2016-09-30       Impact factor: 14.432

6.  Inflammatory Mechanisms Associated with Prostatic Inflammation and Lower Urinary Tract Symptoms.

Authors:  Jennifer L St Sauver; Steven J Jacobsen
Journal:  Curr Prostate Rep       Date:  2008-05-01

7.  Elevated expression of HIF-lα in actively growing prostate tissues is associated with clinical features of benign prostatic hyperplasia.

Authors:  Fei Wu; Sentai Ding; Xin Li; Hui Wang; Shuai Liu; Haihu Wu; Dongbin Bi; Kejia Ding; Jiaju Lu
Journal:  Oncotarget       Date:  2016-03-15

8.  The effect of urethral catheterization on the level of prostate-specific antigen.

Authors:  Mohammad Hossein Izadpanahi; Hojatollah Salimi; Amir Javid; Salman Eslami
Journal:  J Res Med Sci       Date:  2017-03-15       Impact factor: 1.852

9.  Prostatic diseases under focus in a university hospital in Eastern Saudi Arabia. A 15-year experience.

Authors:  Areej M Al Nemer; Reem B Aldamanhori
Journal:  Saudi Med J       Date:  2015-11       Impact factor: 1.484

10.  The effect of prostate tissue inflammation in benign prostatic hyperplasia on enhancer of zeste homolog 2 ribonucleic acid expression.

Authors:  May Al-Maghrebi; Elijah O Kehinde; Fahd Al-Mulla; Jehoram T Anim
Journal:  Ann Saudi Med       Date:  2012 May-Jun       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.